• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境暴露物在间质性肺疾病患者中的识别和处理:证据回顾和实际考虑。

Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.

机构信息

Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington Medical Center, Seattle, WA.

出版信息

Chest. 2021 Jul;160(1):219-230. doi: 10.1016/j.chest.2021.02.021. Epub 2021 Feb 18.

DOI:10.1016/j.chest.2021.02.021
PMID:33609518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8295910/
Abstract

A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.

摘要

吸入环境物质与间质性肺疾病(ILD)之间的关系早已得到认可。过敏性肺炎是一种由环境引起的弥漫性实质性肺疾病。除了过敏性肺炎外,还已经证明家庭和职业暴露会影响其他 ILD 的发病和进展,包括特发性间质性肺炎,如特发性肺纤维化。对出现 ILD 的患者进行临床评估的一个关键组成部分包括阐明完整的暴露史,这可能会影响 ILD 的诊断分类及其治疗。目前,对于 ILD 患者的家庭或工作场所环境中的潜在有害暴露,尚无标准化的环境评估或修复方法。本文讨论了环境因素对 ILD 发病机制的影响,并借鉴哮喘和职业医学文献来阐述对环境因素进行专业评估对 ILD 发展和进展的潜在作用。尽管有几项报告表明对哮喘或某些职业暴露患者进行环境评估有益,但关于更广泛人群中获益的信息不足可能会限制其应用。确定急性和慢性 ILD 中环境评估和修复的可行性、长期结果和成本效益应成为未来研究的重点。

相似文献

1
Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.环境暴露物在间质性肺疾病患者中的识别和处理:证据回顾和实际考虑。
Chest. 2021 Jul;160(1):219-230. doi: 10.1016/j.chest.2021.02.021. Epub 2021 Feb 18.
2
A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.全面评估环境暴露和病史可指导间质性肺疾病的多学科讨论。
Respir Med. 2021 Apr;179:106333. doi: 10.1016/j.rmed.2021.106333. Epub 2021 Feb 11.
3
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.特发性肺纤维化及其他间质性肺疾病患者家庭和职业性吸入暴露的特征和流行率。
Chest. 2021 Jul;160(1):209-218. doi: 10.1016/j.chest.2021.02.026. Epub 2021 Feb 20.
4
Environmental and occupational exposures in interstitial lung disease.环境和职业暴露与间质性肺疾病。
Curr Opin Pulm Med. 2022 Sep 1;28(5):414-420. doi: 10.1097/MCP.0000000000000894. Epub 2022 Jul 16.
5
Scoping review of exposure questionnaires and surveys in interstitial lung disease.特发性肺纤维化(IPF)是一种慢性、进行性、纤维化性间质性肺疾病,具有高度的异质性和病死率。 2011 年美国胸科学会(ATS)和欧洲呼吸学会(ERS)联合发布的 IPF 临床诊断和治疗指南中,明确了 IPF 的诊断标准。 然而,由于 IPF 的临床表现多样,诊断较为困难,容易误诊和漏诊。 因此,对于 IPF 的高危人群,需要进行早期筛查和诊断,以提高 IPF 的早期诊断率和生存率。
BMJ Open Respir Res. 2024 May 15;11(1):e002155. doi: 10.1136/bmjresp-2023-002155.
6
Mechanisms and management of cough in interstitial lung disease.间质性肺疾病咳嗽的机制与管理。
Expert Rev Respir Med. 2023 Dec;17(12):1177-1190. doi: 10.1080/17476348.2023.2299751. Epub 2023 Dec 30.
7
Occupational interstitial lung diseases.职业性间质性肺疾病。
J Intern Med. 2023 Dec;294(6):798-815. doi: 10.1111/joim.13707. Epub 2023 Aug 7.
8
Advances in the identification and management of progressive pulmonary fibrosis: perspective from Chinese experts.特发性肺纤维化的识别与管理进展:中国专家观点。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241288417. doi: 10.1177/17534666241288417.
9
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.纤维化间质性肺疾病患者的吸入暴露:加拿大肺纤维化登记处的临床表现、肺功能和生存率。
Respirology. 2022 Aug;27(8):635-644. doi: 10.1111/resp.14267. Epub 2022 May 5.
10
Interstitial Lung Diseases in Developing Countries.发展中国家的间质性肺疾病。
Ann Glob Health. 2019 Jan 22;85(1):4. doi: 10.5334/aogh.2414.

引用本文的文献

1
Identification of early genes in the pathophysiology of fibrotic interstitial lung disease in a new model of pulmonary fibrosis.在一种新的肺纤维化模型中鉴定纤维化间质性肺疾病病理生理学中的早期基因。
Cell Mol Life Sci. 2025 Mar 13;82(1):115. doi: 10.1007/s00018-025-05620-0.
2
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.纤维化间质性肺疾病临床护理中的多学科团队:当前观点
Eur Respir Rev. 2022 Sep 7;31(165). doi: 10.1183/16000617.0003-2022. Print 2022 Sep 30.
3
Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease.纤维化间质性肺疾病的诊断与药物治疗
Life (Basel). 2023 Feb 21;13(3):599. doi: 10.3390/life13030599.
4
The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.家族性肺纤维化中暴露与疾病特征的关系。
Ann Am Thorac Soc. 2022 Dec;19(12):2003-2012. doi: 10.1513/AnnalsATS.202203-267OC.
5
Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.揭开特发性间质性肺炎的神秘面纱:间质性肺疾病需要更多病因导向的命名法。
Expert Rev Respir Med. 2022 Feb;16(2):235-245. doi: 10.1080/17476348.2022.2030710. Epub 2022 Jan 31.

本文引用的文献

1
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
2
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.澳大利亚特发性肺纤维化的职业和环境风险因素:病例对照研究。
Thorax. 2020 Oct;75(10):864-869. doi: 10.1136/thoraxjnl-2019-214478. Epub 2020 Jul 13.
3
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.家族性间质性肺疾病风险个体的放射学异常的发展和进展。
Am J Respir Crit Care Med. 2020 May 15;201(10):1230-1239. doi: 10.1164/rccm.201909-1834OC.
4
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis.用于慢性过敏性肺炎的系统推导暴露评估工具。
Chest. 2020 Jun;157(6):1506-1512. doi: 10.1016/j.chest.2019.12.018. Epub 2020 Jan 17.
5
The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.非恶性呼吸系统疾病的职业负担。美国胸科学会和欧洲呼吸学会官方声明。
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1312-1334. doi: 10.1164/rccm.201904-0717ST.
6
Asthma, COPD, and home environments: Interventions with older adults.哮喘、COPD 与家庭环境:针对老年人的干预措施。
Ann Allergy Asthma Immunol. 2019 May;122(5):486-491. doi: 10.1016/j.anai.2019.02.026. Epub 2019 Mar 1.
7
Role of Antigen Type in Survival in Chronic Hypersensitivity Pneumonitis.抗原类型在慢性过敏性肺炎生存中的作用。
Lung. 2019 Feb;197(1):113-114. doi: 10.1007/s00408-018-0187-6. Epub 2018 Dec 14.
8
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.过敏性肺炎:影像学表型与不同的生存时间和肺功能轨迹相关。
Chest. 2019 Apr;155(4):699-711. doi: 10.1016/j.chest.2018.08.1076. Epub 2018 Sep 19.
9
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
10
Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.接触有机粉尘并被诊断为特发性肺纤维化的患者的临床行为。
Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.